MIND MEDICINE MINDMED INC (MNMD) Stock Analyst Ratings
USA - NASDAQ:MNMD - CA60255C8850 - Common Stock
12.29 USD
-1.91 (-13.45%)
12.4094 USD
+0.12 (+0.97%)
ChartMill assigns a Buy % Consensus number of 85% to MNMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 25.41. This target is 106.73% above the current price.
MNMD was analyzed by 17 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about MNMD.
In the previous month the buy percentage consensus was at a similar level.
MNMD was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-13 | Needham | Initiate | Buy |
| 2025-08-04 | Oppenheimer | Reiterate | Outperform |
| 2025-08-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-07 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-28 | Evercore ISI Group | Initiate | Outperform |
| 2024-12-20 | Chardan Capital | Initiate | Buy |
| 2024-12-17 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-24 | Roth MKM | Maintains | Buy -> Buy |
| 2024-06-21 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-05-28 | Baird | Initiate | Outperform |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-15 | Leerink Partners | Initiate | Outperform |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-07 | Roth MKM | Maintains | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-10-23 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-04 | EF Hutton | Reiterate | Buy -> Buy |
MIND MEDICINE MINDMED INC / MNMD FAQ
Can you provide the average price target for MIND MEDICINE MINDMED INC stock?
17 analysts have analysed MNMD and the average price target is 25.41 USD. This implies a price increase of 106.73% is expected in the next year compared to the current price of 12.29.
How do analysts rate MIND MEDICINE MINDMED INC (MNMD)?
The consensus rating for MIND MEDICINE MINDMED INC (MNMD) is 84.7059 / 100 . This indicates that analysts generally have a positive outlook on the stock.